Generation Bio (GBIO) News Today → Does this chart look familiar? (From InvestorPlace) (Ad) Free GBIO Stock Alerts $2.84 -0.15 (-5.02%) (As of 05/13/2024 ET) Add Compare Share Share HeadlinesStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial Media All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative May 13 at 11:05 PM | investorplace.comGBIO Stock Earnings: Generation Bio Misses EPS, Beats Revenue for Q1 2024May 13 at 4:05 PM | globenewswire.comGeneration Bio Announces Recent Business Highlights and First Quarter 2024 Financial ResultsMay 9, 2024 | globenewswire.comGeneration Bio Announces the Presentation of Preclinical Data on iqDNA and ctLNP Platforms at the ASGCT 27th Annual MeetingApril 22, 2024 | globenewswire.comGeneration Bio Announces the Acceptance of Five Abstracts and an Invited Oral Presentation at the American Society of Gene and Cell Therapy (ASGCT) 27th Annual MeetingApril 10, 2024 | marketbeat.comNeedham & Company LLC Reaffirms Buy Rating for Generation Bio (NASDAQ:GBIO)Needham & Company LLC restated a "buy" rating and set a $10.00 target price on shares of Generation Bio in a report on Wednesday.April 2, 2024 | globenewswire.comGeneration Bio to Present at the 23rd Annual Needham Virtual Healthcare ConferenceApril 1, 2024 | marketbeat.comGeneration Bio Co. (NASDAQ:GBIO) Given Consensus Rating of "Hold" by AnalystsShares of Generation Bio Co. (NASDAQ:GBIO - Get Free Report) have received a consensus recommendation of "Hold" from the six brokerages that are presently covering the firm, Marketbeat reports. Four research analysts have rated the stock with a hold recommendation and two have assigned a buy recomMarch 31, 2024 | marketbeat.comGeneration Bio Co. (NASDAQ:GBIO) Short Interest UpdateGeneration Bio Co. (NASDAQ:GBIO - Get Free Report) was the target of a significant drop in short interest in March. As of March 15th, there was short interest totalling 1,270,000 shares, a drop of 11.8% from the February 29th total of 1,440,000 shares. Based on an average daily volume of 327,000 shares, the short-interest ratio is presently 3.9 days. Approximately 2.6% of the company's stock are short sold.March 29, 2024 | marketbeat.comGeneration Bio (NASDAQ:GBIO) Shares Up 10%Generation Bio (NASDAQ:GBIO) Trading 10% HigherMarch 17, 2024 | finance.yahoo.comGBIO May 2024 7.500 callMarch 16, 2024 | finance.yahoo.comGBIO Apr 2024 5.000 callMarch 8, 2024 | finance.yahoo.comGeneration Bio Co Reports Full Year and Q4 2023 Financial OutcomesMarch 7, 2024 | finanznachrichten.deGeneration Bio Co.: Generation Bio Reports Business Highlights and Fourth Quarter and Full Year 2023 Financial ResultsMarch 7, 2024 | marketbeat.comGeneration Bio Co. (NASDAQ:GBIO) Receives Average Rating of "Hold" from BrokeragesShares of Generation Bio Co. (NASDAQ:GBIO - Get Free Report) have been given a consensus recommendation of "Hold" by the six analysts that are presently covering the stock, Marketbeat.com reports. Four equities research analysts have rated the stock with a hold recommendation and two have assignedMarch 7, 2024 | marketbeat.comGeneration Bio (NASDAQ:GBIO) PT Lowered to $10.00Needham & Company LLC decreased their target price on shares of Generation Bio from $14.00 to $10.00 and set a "buy" rating on the stock in a research note on Thursday.March 7, 2024 | marketbeat.comGeneration Bio (NASDAQ:GBIO) Stock Rating Reaffirmed by WedbushWedbush reaffirmed an "outperform" rating and set a $5.00 price objective on shares of Generation Bio in a report on Thursday.March 6, 2024 | markets.businessinsider.comGBIO Stock Earnings: Generation Bio Misses EPS, Beats Revenue for Q4 2023March 6, 2024 | globenewswire.comGeneration Bio Reports Business Highlights and Fourth Quarter and Full Year 2023 Financial ResultsFebruary 27, 2024 | globenewswire.comGeneration Bio to Present at the 2024 TD Cowen Health Care ConferenceFebruary 25, 2024 | finance.yahoo.comGeneration Bio (NASDAQ:GBIO) Is In A Good Position To Deliver On Growth PlansFebruary 23, 2024 | benzinga.comGeneration Bio Stock (NASDAQ:GBIO), Short Interest ReportFebruary 21, 2024 | investing.comGeneration Bio Co (GBIO)February 21, 2024 | msn.comWhat Is Biohacking And Why Gen Z And Millennials Are Obsessed With ItFebruary 20, 2024 | marketbeat.comGeneration Bio (GBIO) Scheduled to Post Quarterly Earnings on WednesdayGeneration Bio (NASDAQ:GBIO) will be releasing earnings on Wednesday, February 21, Yahoo Finance reports.February 16, 2024 | marketbeat.comShort Interest in Generation Bio Co. (NASDAQ:GBIO) Grows By 16.0%Generation Bio Co. (NASDAQ:GBIO - Get Free Report) was the recipient of a significant increase in short interest during the month of January. As of January 31st, there was short interest totalling 1,450,000 shares, an increase of 16.0% from the January 15th total of 1,250,000 shares. Approximately 3.0% of the shares of the stock are sold short. Based on an average daily trading volume, of 583,600 shares, the days-to-cover ratio is currently 2.5 days.February 6, 2024 | bizjournals.comGeneration Bio ends Waltham lease but landlord fights backFebruary 3, 2024 | msn.comGeneration Bio Co. Ends Lease Citing Landlord BreachJanuary 30, 2024 | msn.comThe booming business of discovering your biological age: This tech company will measure it starting at $400 per yearJanuary 28, 2024 | marketbeat.comGeneration Bio Co. (NASDAQ:GBIO) Sees Significant Increase in Short InterestGeneration Bio Co. (NASDAQ:GBIO - Get Free Report) was the recipient of a significant growth in short interest during the month of January. As of January 15th, there was short interest totalling 1,250,000 shares, a growth of 23.8% from the December 31st total of 1,010,000 shares. Currently, 2.6% of the shares of the stock are sold short. Based on an average daily trading volume, of 809,700 shares, the days-to-cover ratio is presently 1.5 days.January 19, 2024 | benzinga.comGeneration Bio Stock (NASDAQ:GBIO) Dividends: History, Yield and DatesJanuary 17, 2024 | entrepreneur.comGeneration Z: Page 4January 14, 2024 | msn.com42 Tiny Observations About Gen Z Culture That Will Be Seriously Enlightening To Other GenerationsJanuary 13, 2024 | marketbeat.comGeneration Bio Co. (NASDAQ:GBIO) Given Average Recommendation of "Hold" by AnalystsGeneration Bio Co. (NASDAQ:GBIO - Get Free Report) has earned an average recommendation of "Hold" from the six ratings firms that are presently covering the company, Marketbeat Ratings reports. Four equities research analysts have rated the stock with a hold recommendation and two have assigned aJanuary 3, 2024 | finance.yahoo.comGeneration Bio to Present at the 42nd Annual J.P. Morgan Healthcare ConferenceDecember 30, 2023 | marketbeat.comGeneration Bio Co. (NASDAQ:GBIO) Short Interest Down 33.2% in DecemberGeneration Bio Co. (NASDAQ:GBIO - Get Free Report) saw a significant drop in short interest in December. As of December 15th, there was short interest totalling 1,350,000 shares, a drop of 33.2% from the November 30th total of 2,020,000 shares. Based on an average trading volume of 799,800 shares, the short-interest ratio is currently 1.7 days. Approximately 2.8% of the company's shares are short sold.December 7, 2023 | finance.yahoo.comCharles Rowland Bought 179% More Shares In Generation BioDecember 6, 2023 | finance.yahoo.comDirector Rowland Charles A Jr Acquires 342,960 Shares of Generation Bio Co (GBIO)November 30, 2023 | markets.businessinsider.comJMP Securities Keeps Their Hold Rating on Generation Bio (GBIO)November 29, 2023 | msn.comGeneration Bio cuts its payroll by 40 percent in latest restructuring moveNovember 29, 2023 | bizjournals.comModerna-partnered gene therapy firm to lay off 68, including two execsNovember 29, 2023 | marketwatch.comGeneration Bio Begins Strategic Reorganization, With 40% Headcount CutNovember 29, 2023 | finance.yahoo.comGeneration Bio Announces Strategic Reorganization to Extend Cash Runway for Development of ctLNP and iqDNA PlatformsNovember 11, 2023 | markets.businessinsider.comHold Rating on Generation Bio: Innovations in Immune-Quiet DNA and ctLNP Delivery System Yet Uncertain Timeline for Hemophilia A ProgramNovember 11, 2023 | markets.businessinsider.comAnalyst Upholds Buy Rating for Generation Bio Based on 3Q23 Earnings and Strong Financial HealthNovember 10, 2023 | msn.comGeneration Bio GAAP EPS of -$0.43November 9, 2023 | finance.yahoo.comGeneration Bio Reports Business Highlights and Third Quarter 2023 Financial ResultsOctober 26, 2023 | finance.yahoo.comGeneration Bio Announces Demonstration of Highly Selective T Cell Transduction In Vivo with Cell-Targeted LNP PlatformOctober 23, 2023 | msn.comJMP Securities Downgrades Generation Bio (GBIO)October 20, 2023 | markets.businessinsider.comJMP Securities downgrades Generation Bio (GBIO) to a HoldOctober 19, 2023 | msn.comTD Cowen Downgrades Generation Bio (GBIO) Get Generation Bio News Delivered to You Automatically Sign up to receive the latest news and ratings for GBIO and its competitors with MarketBeat's FREE daily newsletter. Email Address Crypto Pioneer Says: “The last crypto bull market has begun.” (Ad)Right now, there’s over $6 trillion in potential investment money waiting on the sidelines. That means this crypto bull market has a lot more room to run before it comes close to being a bubble. Click here if you’d like to learn more about these five cryptos… GBIO Media Mentions By Week GBIO Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. GBIO News Sentiment▼0.290.57▲Average Medical News Sentiment GBIO News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. GBIO Articles This Week▼51▲GBIO Articles Average Week Get Generation Bio News Delivered to You Automatically Sign up to receive the latest news and ratings for GBIO and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: OMER News OVID News ATOS News RENB News RIGL News GALT News MACK News TRVI News LFCR News GTHX News Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:GBIO) was last updated on 5/14/2024 by MarketBeat.com Staff From Our PartnersGuard Against the Coming Financial UpheavalPorter & CompanyClaim Your Complimentary Bitcoin RewardCrypto Swap ProfitsConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareColonial MetalsTech GIANT’s Plans to Revolutionize Crypto…Crypto 101 MediaElon’s New Device is About to Shock the WorldInvestorPlaceCharles Payne Demystifies OptionsUnstoppable ProsperityForget Bitcoin. Crypto Millionaire Predicts 8,788% Gains For THISParadigm PressGold ManiaStansberry Research Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Generation Bio Co. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
